Rights and permissions
About this article
Cite this article
Goserelin provides early QOL benefit in breast cancer. Pharmacoecon. Outcomes News 440, 10 (2003). https://doi.org/10.1007/BF03277108
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277108